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Colorectal cancer in South Africa: A heritable cause 
suspected in many young black patients
L Cronjé, A C Paterson, P J Becker
Colorectal carcinoma (CRC) is uncommon in developing 
countries, typically in Africa and Asia.1 It is generally a disease 
of older people, and is associated with a Western-style diet 
and a sedentary lifestyle. However, the age at which patients 
present with CRC may be a marker for the involvement of 
hereditary factors which often have specific pathological 
features.
Over the past decade, the overall incidence of CRC in 
South Africa has increased markedly. In 1989, CRC was the 
10th most common cancer diagnosed in males and females 
in South Africa but was more recently ranked among the 
foremost 5 cancers (5th among males and 3rd among females).2 
The epidemiology of CRC in white South Africans appears 
to follow the classic Western trend, although the molecular 
pathology has not been comprehensively investigated. CRC 
among black South Africans is far less common, but there is 
evidence that numbers have been increasing in some centres.3 
Furthermore, disproportionately large numbers of young 
black patients seem to be presenting with CRC,4 a trend which 
appears to be common among countries throughout the 
African continent.
Classically, CRC is associated with chromosomal instability 
and mutations of multiple tumour suppressor genes and 
oncogenes, including APC, K-ras and p53. Alternatively, 
the tumour may develop through microsatellite instability 
(MSI), which may be sporadic (10% of cases) or hereditary, 
as evident in hereditary non-polyposis colorectal cancer 
(HNPCC) (in 90% of cases).5 MSI is associated with mutations 
in the DNA mismatch repair genes hMLH1 and hMSH2, 
and less frequently hMSH6 and PMS2, leading to the rapid 
development of neoplasms through the accumulation of 
mutations.6 Both of these pathways follow the adenoma-
carcinoma sequence.
Recently, an alternative ‘serrated adenoma’ pathway 
was proposed, involving the formation of a tumour from 
hyperplastic polyps and adenomas through intermediate 
serrated adenomas.7 These tumours show a low level of MSI 
(MSI-L) together with a methylation phenotype characterised 
by the methylation of CpG islands within the promoter regions 
of genes such as hMLH18 and O-6-methylguanine DNA-
methyltransferase (MGMT).9 Serrated neoplasia is less common 
and could possibly explain the occurrence of CRC among some 
young patients. This is frequently referred to as the ‘methylator 
pathway’.
This study evaluates the occurrence and morphological 
features of CRC in South African patients over a 13-year 
period. Many younger patients (<50 years) were black South 
Africans and presented with proximal tumours that were often 
poorly differentiated or mucinous and with significant risk of 
loss of hMSH2 protein expression. These are features associated 
with a heritable cause of colon cancer and would aid in its 
early diagnosis and improved prognosis.
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Background. Colorectal carcinoma (CRC) has a low incidence 
among the black African population. Largely unrecognised 
in the scientific literature is the fact that a disproportionately 
large number of young black patients (<50 years old) present 
with CRC.
Objectives. To analyse those tumours, which we propose may 
link them to morphological features associated with known 
genetic pathways.
Methods. A retrospective review of South African patients 
histologically diagnosed as having CRC by the Division of 
Anatomical Pathology, National Health Laboratory Service 
(NHLS) and the University of the Witwatersrand (1 732 
patients from 1990 to 2003). The histology was fully reviewed 
in 609 patients (1997 - 2002), and all specimens from patients 
<50 years of age were subjected to immunohistochemistry 
tests for mismatch repair proteins, as well as APC and p53 
proteins.
Results. Most young patients (<50 years) were black (41% 
v. 10% white; p≤0.001). Blacks had predominantly proximal 
tumours and significantly more poorly differentiated and/or 
mucinous tumours (p=0.006), and loss of mismatch repair 
protein expression was more evident than in whites.
Conclusions. It seems likely that CRC in young blacks 
develops through the accumulation of mutations, most 
probably via mismatch repair deficiency or promoter 
methylation, which in turn is linked to poor differentiation 
and a mucinous architecture.
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Methods
Patients/tumour specimens
The data were retrospective, comprising all biopsy and 
resection specimens that fulfilled the histological criteria for 
adenocarcinoma of the colon or rectum from 1990 to 2003 from 
the records of the Division of Anatomical Pathology, NHLS and 
the University of the Witwatersrand, which comprised cases 
seen at academic and public sector hospitals in the Gauteng, 
Mpumalanga and North-West provinces of South Africa. All 
cases were stratified by age (<50 years of age or >50 years 
of age at diagnosis), gender, ethnicity and tumour location 
(identified from histology reports). The study was approved by 
the Ethics Committee of the University of the Witwatersrand 
(clearance number 9/11/88).
From 1990 to 2003, 1 732 black and white South African 
patients (961 and 771 respectively) with colorectal cancer were 
identified. Because the study was retrospective, family histories 
were not obtainable. The reports of all cases were examined, 
and formal pathological review of cases was limited to 609 
cases reported between 1998 and 2002. The original histological 
details were reviewed in consultation with a single pathologist 
(ACP), without knowledge of patient demographics and 
tumour sites. Each site was recorded as distal (descending 
colon, sigmoid, rectum) or proximal (caecum, ascending 
colon, transverse colon to the splenic flexure). Tumours were 
graded as well, moderately (low grade) or poorly differentiated 
(high grade) according to accepted morphological features.1 
Mucinous and signet-ring tumours were considered to be of 
high grade.1 A subset of more recently diagnosed cases (1998 - 
2002) identified in patients <50 years, regardless of race, and an 
equivalent number of patients >50 years, were then subjected 
to immunohistochemical analysis.
Immunohistochemistry
Table I summarises the antibody specifications. 
Immunohistochemical staining was performed on formalin-
fixed, paraffin-embedded tissue sections by means of 
routine techniques using a DakoCytomation Autostainer 
(DakoCytomation, Denmark). Briefly, heat-induced antigen 
retrieval was performed using a combination of microwaving 
and pressure cooking, endogenous peroxidase was blocked 
in 3% H2O2 in dH2O for 15 minutes, and nonspecific antigen 
activity was blocked by immersion of sections in 5% normal 
goat sera. Sections were then exposed to the monoclonal 
antibodies in a humidified atmosphere, rinsed and treated 
with a peroxidase-conjugated polymer, and secondary 
antibody directed against rabbit and mouse immunoglobulin 
(ChemMate Dako EnVision Detection kit, DakoCytomation, 
Denmark). Slides were again washed and incubated with 3,3’-
diaminobenzidine (DAB) chromogen, washed with H2O2 and 
counterstained with haematoxylin, dehydrated and mounted. 
Appropriate positive and negative controls were used for each 
run. Slides were considered unsuitable for analysis when there 
was complete absence of signal in both mucosa and tissue 
lymphocytes. In some cases, there was insufficient tissue for 
full immunohistochemical analysis.
Statistical analysis
Statistical comparisons between groups were completed using 
the two-sided Fisher’s exact test. Patients were analysed on the 
basis of ethnicity (black v. white), age (<50 years v. >50 years), 
gender (male v. female) and tumour site. Multinomial logistical 
regression analysis was performed to calculate odds ratios. 
All statistical analyses were compiled by Stata Intercooled 7.0 
(Stata, College Station, Tex. USA). At p<0.05 the differences 
were considered statistically significant.
Results
Patient demographics
A total of 1 732 patients (961 blacks and 771 whites) with 
histologically diagnosed CRC were identified; 73% (1 259/ 
1 731) were >50 years of age and 27% (472/1 731) were ≤50 
years (age range 14 - 100 years, mean 59). Distinct differences 
were noted between black and white cohorts. Black patients 
diagnosed with CRC were predominantly male (55%), while 
53% of white patients were female (p=0.001). Similarly, 83% 
of black patients were ≤50 years of age compared with only 
10% of younger whites (p≤0.001). Tumour location showed no 
correlation with race (p=1.000; 95% confidence interval (CI)).
Pathological characteristics
All young patients (<50 years, N=69) presented predominantly 
with low-grade tumours (65%; 109/169), with 19% (32/169) 
being poorly differentiated; of these, 9% (16/169) were 
mucinous (p≤0.001). In contrast, 82% (372/452) of tumours in 
older patients (>50 years, N=452) were of low grade, while 
10% (44/452) were poorly differentiated and, of these, 4% were 
mucinous (18/452) (p≤0.001). Young patients also presented 
more commonly with high-grade tumours showing a signet 
ring cell morphology (11%; 14/125) compared with older 
patients (3%; 12/382) (p≤0.001).
When compared with white patients, 15% of black patients 
(N=367) had poorly differentiated tumours (p=0.001), of which 
7% (27/367) were exclusively mucinous. In contrast, whites 
Table I. Details of antibodies used for 
immunohistochemistry
Antigen       Antibody clone     Dilution         Source
APC       H-290                    1:200               Santa Cruz
p53       PAb240    1:75           Dako Cytomation
hMLH1       G168-15    1:100               BD Pharmingen
hMSH2       G219-1129    1:200               BD Pharmingen
hMSH6       Clone 44    1:500               BD Transduction
MGMT       MT23.2    1:75           Zymed
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(N=245) showed fewer poorly differentiated (8%; 21/245) and 
purely mucinous tumours (3%; 7/245) (p=0.001).
Immunohistochemistry
Black patients more frequently showed loss of expression of the 
mismatch repair gene proteins hMLH1 (23%; 29/128) (p=0.121), 
hMSH2 (12%; 16/129) (p=0.013) and hMSH6 (43%; 54/126) 
(p=0.210) (Table II) (Fig. 1, A). In contrast, white patients more 
frequently showed loss of APC protein expression (15%; 9/62) 
(p=0.648) and the accumulation of mutant p53 protein within 
cancer cells (58%; 37/64) (p=0.047) (Fig. 1, B). Loss of MGMT 
protein expression was observed in similar percentages in both 
ethnic groups, i.e. 27% blacks (33/123) and 26% whites (16/62) 
(p=1.000).
In summary, there was a significant risk (odds ratio (OR) 
1.9) for young black male patients to present with poorly 
differentiated tumours with a degree of mucin expression, 
as calculated through multinomial regression analysis. In 
addition, young black patients have a further additional risk of 
developing a tumour with an exclusively mucinous appearance 
and with a loss of hMSH2 protein expression (OR 6.5) while 
they were less likely to show accumulation of mutant p53 
protein in cancer cells (OR 0.6).
Discussion
We investigated the pathological features of CRC among 
patients presenting to academic and public sector hospitals 
in South Africa’s most densely populated regions. Among 
the 961 black patients, 41% were aged ≤50 years, compared 
with the equivalent of only 10% among white patients. Of 
black patients, 29% were <40 years and 11.6% <30 years old, 
supporting studies that have identified disproportionate 
numbers of young South African black patients presenting with 
CRC.3,4
An increased incidence of colon cancer among young black 
patients has also been identified outside Africa. A higher 
proportion of African-American and Hispanic patients between 
20 and 40 years of age has been reported, compared with older 
patients (60 - 80 years) of the same ethnicity.10 The tumours 
in the younger patients were poorly differentiated and/or 
mucinous, which is similar to the finding of our study.
An association between MSI-H CRC genotype and 
phenotype in African-American patients has been identified.11 
These microsatellite-unstable tumours showed distinct clinical 
and pathological features including proximal location, high-
grade and/or mucinous histology, the presence of tumour-
infiltrating lymphocytes and mismatch repair gene deficiency, 
most frequently in the hMLH1 and hMSH2 genes.12 Young 
black males in our series presented with a similar morphology 
as well as a risk of absent hMLH1 protein expression and an 
increased possibility of loss of hMSH2 protein expression.
Hereditary non-polyposis colorectal cancer (HNPCC) shows 
similar features, including presentation at average age <50 
years.13 However, diagnosis of HNPCC relies on fulfilling the 
Amsterdam and Bethesda criteria, and this was unavailable in 
our series. The strict Amsterdam criteria may lead to under-
diagnosis of HNPCC, and it is suggested in the 1997 Bethesda 
guidelines that CRC diagnosed at a young age, even without 
a family history, may indeed have a genetic element leading 
to cancer development and that such patients should be tested 
for HNPCC.14 Early screening for HNPCC15 failed to identify 
new HNPCC cases and concurred with the revised Bethesda 
guidelines16 that excluded microsatellite instability testing 
in all adenomas from patients <40 years of age. However, 
Velayos and co-workers commented on the possibility of 
using direct germline testing as an alternative, as this shows 
increased sensitivity.15 As such, confirming the CRC cases in 
our young patients as being HNPCC by germline detection of 
microsatellite instability may be appropriate.
Microsatellite-unstable tumours also occur within 10 - 15% of 
sporadic CRCs.17 The difference in the development of sporadic 
versus hereditary CRC is thought to invoke the ‘methylator 
Table II. Differences between blacks and whites in the loss of protein expression, as assessed by immunohistochemistry*
          Blacks           Whites            p-value
hMLH1          23% (29/128)           13% (8/63)            0.121
hMSH2          12% (16/129)           2% (1/65)            0.013
hMSH6          43% (54/126)           33% (21/64)            0.210
APC          12% (15/124)           15% (9/62)            0.648
p53          42% (54/128)           58% (37/64)            0.047
MGMT          27% (33/123)           26% (16/62)            1.000
*Values are given as a percentage of the overall distribution between the different variables.

Fig. 1. Examples of results obtained for the immunohistochemical detec-
tion of protein expression in colorectal carcinoma. Loss of MSH2 protein 
expression is evident in tumour as opposed to non-tumour tissue (A), 
while positive staining for the mutant p53 protein in tumour but not non-
tumour tissue is evident (B).
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pathway’. Promoter regions are rich in CpG islands, such 
as those of the hMLH1 and O-6-methylguanine DNA-
methyltransferase (MGMT) genes, and hence susceptible to 
hypermethylation, resulting in their transcriptional silencing.8,9 
Microsatellite instability in sporadic CRC has been shown to 
be due to methylation of the hMLH1 gene18 and is common 
in proximal tumours.19 After identifying MSI-H in the colon 
cancers from African-American patients, Ashktorab et al. 
noted that the MSI-H tumours are likely to be attributable to 
promoter methylation as 85% (29/34) of them showed hMLH1 
promoter methylation.20 Although not statistically significant, 
compared with older whites, young black patients showed 
a trend towards an increased risk for absent hMLH1 protein 
expression. Further studies into the methylation status of this 
promoter region would provide insight into the CpG island 
methylator phenotype of these tumours.
Methylation of the MGMT gene is characteristic of CRC 
with low-level microsatellite instability.21 This has become 
associated with the ‘serrated adenoma pathway’22 that 
involves the formation of carcinoma from hyperplastic polyps 
and adenomas through intermediate serrated adenomas. 
Cancers associated with this pathway have been shown to 
secrete abundant mucin.23 We report 26% (49/185) of cases 
showing loss of expression of MGMT, which could imply 
hypermethylation of this promoter region. Only 3 serrated 
adenomas were identified, in the later years of our study and 
in older female white patients. Our low percentage of serrated 
adenomas may indicate a low detection rate rather than a low 
incidence, and calls for careful identification of the entity.
Tumours of the serrated adenoma pathway are often found 
in the sigmoid colon and rectum24 and, through the associated 
p53 gene mutation, may indicate the involvement of APC 
gene mutations. Black South African patients were less likely 
than whites to show an accumulation of mutant p53 in cancer 
cells in our series. p53 mutations are associated with the 
well-known adenoma-carcinoma sequence of events that is 
initiated by mutations in the APC gene. However, proximal 
tumours developed in a p53-independent manner which may 
indicate a preference towards the mutator phenotype with 
the accumulation of mutations owing to mismatch repair 
deficiency. Our white patients presented more frequently with 
both loss of expression of the APC protein and accumulation 
of p53 in cancer cells; it therefore appears that their tumours 
develop through the suppressor pathway involving mutations 
of tumour-suppressor genes that are thought to be diet- and/or 
environmentally related.
Our subjective impression, and that of other units,25 is that 
the incidence of CRC is increasing, which may be validated by 
further updates of the Cancer Registry of South Africa.2
Young black patients were more likely to be male, with 
poorly differentiated and/or mucinous proximal tumours and 
with loss of hMSH2 protein expression. Therefore, it seems 
likely that CRC in these patients develops predominantly 
through a heritable cause linked to a deficiency in mismatch 
repair caused by promoter methylation. Further analysis of 
microsatellite instability and methylation status would aid in 
the additional characterisation of the pathway involved in the 
development of CRC in young black patients.
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